Drug
Glucagon
Glucagon: highest development phase Approved, developed by Eli Lilly, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Eli Lilly, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| GLUCAGON | Approved | |
| Glucagon NCT04712266 | Phase 1 | Type 1 Diabetes Mellitus With Hypoglycemia |
Latest
No recent events.
Follow Glucagon on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.